Stay up-to-date on the latest rare disease news by reading the top 5 articles of the week.
Rare Disease Report® Editorial Staff
Advertisement
Articles by Rare Disease Report® Editorial Staff
Stay up-to-date on the latest rare disease news by reading the top 5 articles of the week.
Pauline Funchain MD, explains her research which focuses on assessing possible underlying genetic and familial factors in melanomas.
Radhakrishnan Ramchandren MD, highlights the recent US Food and Drug Administration’s (FDA) approval and advantages of ADCETRIS (brentuximab vedotin) in combination with chemotherapy for advanced stage, classic Hodgkin lymphoma.
The FDA has accepted the NDA and granted Priority Review to Firdapse for the treatment of LEMS.
Advertisement
Advertisement
Advertisement
Trending on HCPLive
1
FDA Approves Risankizumab for Pediatric Plaque Psoriasis, Psoriatic Arthritis
2
New AI Tool May Effectively Predict Sudden Cardiac Arrest Risk in Otherwise Healthy Patients
3
FDA Approves Roflumilast 0.3% Cream for PsO in Children 2-5 Years
4
Q3 2026 Preview: 4 FDA Decisions to Watch
5